You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Original Contributions Efficacy and Safety of Emtricitabine vs Stavudine in Combination Therapy in Antiretroviral-Naive Patients: A Randomized Trial
Michael S. Saag; Pedro Cahn; François Raffi; Marcelo Wolff; Daniel Pearce; Jean-Michel Molina; William Powderly; Audrey L. Shaw; Elsa Mondou; John Hinkle; Katyna Borroto-Esoda; Joseph B. Quinn; David W. Barry; Franck Rousseau; for the FTC-301A Study Team
JAMA 2004; 292: 180-189.
[Abstract][Full text][PDF]
Original Contributions Efficacy and Safety of Tenofovir DF vs Stavudine in Combination Therapy in Antiretroviral-Naive Patients: A 3-Year Randomized Trial
Joel E. Gallant; Schlomo Staszewski; Anton L. Pozniak; Edwin DeJesus; Jamal M. A. H. Suleiman; Michael D. Miller; Dion F. Coakley; Biao Lu; John J. Toole; Andrew K. Cheng; for the 903 Study Group
JAMA 2004; 292: 191-201.
[Abstract][Full text][PDF]
Preliminary Communications Growth Hormone–Releasing Hormone in HIV-Infected Men With Lipodystrophy: A Randomized Controlled Trial
Polyxeni Koutkia; Bridget Canavan; Jeff Breu; Martin Torriani; John Kissko; Steven Grinspoon
JAMA 2004; 292: 210-218.
[Abstract][Full text][PDF]
Reviews Clinical Trials in Sub-Saharan Africa and Established Standards of Care: A Systematic Review of HIV, Tuberculosis, and Malaria Trials
David M. Kent; D. Mkaya Mwamburi; Michael L. Bennish; Bruce Kupelnick; John P. A. Ioannidis
JAMA 2004; 292: 237-242.
[Abstract][Full text][PDF]
Letters Aggressive Lipid-Lowering Therapy and Regression of Coronary Atheroma
Original Contributions Enoxaparin vs Unfractionated Heparin in High-Risk Patients With Non–ST-Segment Elevation Acute Coronary Syndromes Managed With an Intended Early Invasive Strategy: Primary Results of the SYNERGY Randomized Trial
